Evidence map›Paper›PMID 41809466›Full record

ArticleWorld journal of hepatology2026

Integrating molecular and immune biomarkers for precision therapy in hepatitis B: Associated hepatocellular carcinoma.

Pranjal Kashiv, Khushboo Saxena, Manish Ramesh Balwani, Vivek Balkrishna Kute

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pranjal KashivDepartment of Nephrology, All India Institute of Medical Sciences, Nagpur 441108, Maharashtra, India.
Khushboo SaxenaDepartment of Nephrology, Institute of Kidney Diseases and Research Center, Ahmedabad 380016, Gujarat, India.
Manish Ramesh BalwaniDepartment of Nephrology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha 442001, Maharashtra, India.
Vivek Balkrishna KuteDepartment of Nephrology, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences, Ahmedabad 380016, Gujarat, India. drvivekkute@rediffmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this editorial, we comment on the article by Wang

Indexed as

CD4+ central memory T cellsHepatitis B virus-associated hepatocellular carcinomaImmune checkpoint inhibitorsLenvatinibLINC01554Multi-omic biomarkersPrecision hepatologySintilimab

Identifiers

PMID41809466
PMCPMC12968698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.